4.5 Article

A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human

Journal

PHYSIOLOGICAL GENOMICS
Volume 29, Issue 2, Pages 99-108

Publisher

AMER PHYSIOLOGICAL SOC
DOI: 10.1152/physiolgenomics.00194.2006

Keywords

metabonomics; metabolic syndrome; biofluids; Zucker rat; db/db mouse; nuclear magnetic resonance spectroscopy; leptin resistance

Funding

  1. Medical Research Council [MC_U142670371, MC_U142661184, MC_UP_1502/1] Funding Source: Medline
  2. Medical Research Council [MC_U142670371, MC_UP_1502/1, MC_U142661184] Funding Source: researchfish
  3. MRC [MC_UP_1502/1, MC_U142661184, MC_U142670371] Funding Source: UKRI

Ask authors/readers for more resources

Type 2 diabetes mellitus is the result of a combination of impaired insulin secretion with reduced insulin sensitivity of target tissues. There are an estimated 150 million affected individuals worldwide, of whom a large proportion remains undiagnosed because of a lack of specific symptoms early in this disorder and inadequate diagnostics. In this study, NMR-based metabolomic analysis in conjunction with multivariate statistics was applied to examine the urinary metabolic changes in two rodent models of type 2 diabetes mellitus as well as unmedicated human sufferers. The db/db mouse and obese Zucker ( fa/fa) rat have autosomal recessive defects in the leptin receptor gene, causing type 2 diabetes. H-1-NMR spectra of urine were used in conjunction with uni- and multivariate statistics to identify disease-related metabolic changes in these two animal models and human sufferers. This study demonstrates metabolic similarities between the three species examined, including metabolic responses associated with general systemic stress, changes in the TCA cycle, and perturbations in nucleotide metabolism and in methylamine metabolism. All three species demonstrated profound changes in nucleotide metabolism, including that of N-methylnicotinamide and N-methyl-2-pyridone-5-carboxamide, which may provide unique biomarkers for following type 2 diabetes mellitus progression.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available